Seth Harmon
Director Financiero/CFO en VIRIDIAN THERAPEUTICS, INC. .
Fortuna: 12 700 $ al 30/04/2024
Cargos activos de Seth Harmon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 12/09/2023 | - |
| Director Financiero/CFO | 12/09/2023 | - | |
| Corporate Officer/Principal | 01/05/2023 | 12/09/2023 |
Historial de carrera de Seth Harmon
Antiguos cargos conocidos de Seth Harmon.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| BIONTECH SE | Director Financiero/CFO | 01/05/2020 | 01/05/2023 |
| NEON THERAPEUTICS, INC. | Corporate Officer/Principal | 01/04/2017 | 01/05/2020 |
Formación de Seth Harmon.
| Northeastern University | Graduate Degree |
| Bowdoin College | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Alemania | 2 |
Operativa
| Director of Finance/CFO | 2 |
| Corporate Officer/Principal | 2 |
| Comptroller/Controller/Auditor | 1 |
Sectorial
| Health Technology | 4 |
| Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| VIRIDIAN THERAPEUTICS, INC. | Health Technology |
| BIONTECH SE | Health Technology |
| Empresas privadas | 1 |
|---|---|
BioNTech US, Inc.
 BioNTech US, Inc. BiotechnologyHealth Technology BioNTech US, Inc. develops novel therapeutics leveraging neoantigen biology to treat cancer. It offers NEO-PV-01, a personalized neoantigen vaccine that builds upon initial clinical trials. The company was founded by James P. Allison, Edward J. Fritsch, Nir Hacohen, Eric S. Lander, Robert Schreiber, Ton Schumacher and Catherine Wu on October 21, 2013 and is headquartered in Cambridge, MA. | Health Technology |
- Bolsa de valores
- Insiders
- Seth Harmon
- Experiencia
